Posts belonging to Category Breaking News

Info from Bateman Horne Center

Simple Way to Assess Orthostatic Intolerance

Gene Study

Dr. Nancy Klimas’ ME/CFS Gene Study at Nova Southeast University is still seeking patient and healthy volunteers. If you are interested, you can send a message to and we will forward it to the study. More information can be found at…/ME+CFS+Genes+Study/1_06vh90p0 This is a chance for both patients and healthy volunteers to participate.

Follow-Up to Letter to NIH Director Collins

Read about the encouraging results at:

First Approved ME/CFS Treatment in the World

Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic First Product Approved for ME/CFS Indication Anywhere in the World. Ampligen Approved in Argentina – First in the World 2016-08-23

2016 Membership Renewal

August is Membership Renewal Month Please support the work of NJME/CFSA.  See information at the link below. 2016-08 Membership Renewal Request

Announcing the Winners of ‪#‎MEAction‬’s Poetry Contest!

Link includes the 10 poems. i.e.…/…/meactions-poetry-contest-winners

Medical Scholarship – See Scholarships tab at top of this page

Facebook Posts

Be sure to check out the NJME/CFSA Facebook page regularly for recent posts.

Trustee Kenneth Friedman, PHD participated in ME/CFS Awareness Day Panel celebrated ME/CFS Awareness Day in the U.S. (May 12th, 2016) by holding a live television panel discussion concerning ME/CFS and Lyme disease on CCTV in Burlington, VT. I was honored to be included in the panel which consisted of physicians, an ME/CFS research and a VT State Senator; all of whom informed the audience […]

Governor Christie Declares May 2016 ME/CFS Awareness Month